Reslizumab in Patients With Severe Asthma Who Failed to Respond to Omalizumab: a Pilot Study
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 20 Apr 2018
At a glance
- Drugs Reslizumab (Primary)
- Indications Asthma
- Focus Therapeutic Use
- 02 Mar 2018 Planned End Date changed from 31 Mar 2018 to 26 Mar 2018.
- 02 Mar 2018 Planned primary completion date changed from 31 Mar 2018 to 26 Mar 2018.
- 02 Mar 2018 Status changed from recruiting to active, no longer recruiting.